Pharmaceutical

BARDA and Tiba Biotech link to develop ‘flu therapeutics

Preclinical biopharmaceutical company Tiba Biotech has announced a partnership with BARDA to develop therapeutics against influenza.

Jul 12, 2024 - 04:00
BARDA and Tiba Biotech link to develop ‘flu therapeutics
Preclinical biopharmaceutical company Tiba Biotech has announced a partnership with BARDA to develop therapeutics against influenza.
Read the original article

Tags:

Previous Article

Respiratory bacteria ‘turns off’ immune system to survive

Next Article

J&J asserts its place in atopic dermatitis space with Yellow Jersey acquisition

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Dutch health minister won’t cover a Gilead cancer drug due to the cost

STAT+: Dutch health minister won’t cover a Gilead cance...

Mar 30, 2023

STAT+: ‘Missed opportunities’: Why a U.K. government plan to disclose financial ties between pharma and docs may fall short

STAT+: ‘Missed opportunities’: Why a U.K. government pl...

Oct 24, 2023

Dermavant maps out atopic dermatitis filing after positive Phase III data 

Dermavant maps out atopic dermatitis filing after posit...

Jan 13, 2024